miR‑124 regulates the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sp7

  • Authors:
    • Jia‑Zhen Tang
    • Xiao Lin
    • Jia‑Yu Zhong
    • Feng Xu
    • Feng Wu
    • Xiao‑Bo Liao
    • Rong‑Rong Cui
    • Fuxingzi Li
    • Ling‑Qing Yuan
  • View Affiliations

  • Published online on: March 18, 2019     https://doi.org/10.3892/mmr.2019.10054
  • Pages: 3807-3814
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs (miRNAs) are novel key regulators of cellular differentiation. miR‑124 has been reported to regulate osteogenic differentiation of bone marrow‑derived mesenchymal stem cells (BMSCs). However, the specific mechanisms involved have not yet been fully elucidated. The present study aimed to investigate the effect of miR‑124 on osteogenic differentiation of BMSCs and its underlying mechanisms. In the present study, it was found that alkaline phosphatase (ALP) activity, osteocalcin (OC) secretion, and the protein levels of osterix (Sp7) and runt‑related transcription factor 2 (Runx2) were significantly increased, whereas the expression of miR‑124 was decreased in a time‑dependent manner during osteogenic differentiation of BMSCs. Following overexpression of miR‑124 via transfection of miR‑124 mimics in BMSCs, Runx2 protein expression and ALP activity were significantly decreased. By contrast, inhibition of miR‑124 expression led to an increase in ALP activity and Runx2 expression. Sp7 expression was suppressed in BMSCs transfected with miR‑124 mimics while increased when miR‑124 expression was inhibited, indicating that miR‑124 regulates the expression of Sp7. Moreover, a luciferase reporter assay further verified that Sp7 is the direct target of miR‑124. Finally, the effect of miR‑124 inhibitor on promoting the differentiation of BMSCs was abolished following treatment with a small interfering RNA targeting Sp7. Taken together, the present study demonstrates that miR‑124 inhibits the osteogenic differentiation of BMSCs by targeting Sp7.
View Figures
View References

Related Articles

Journal Cover

May-2019
Volume 19 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tang JZ, Lin X, Zhong JY, Xu F, Wu F, Liao XB, Cui RR, Li F and Yuan LQ: miR‑124 regulates the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sp7. Mol Med Rep 19: 3807-3814, 2019.
APA
Tang, J., Lin, X., Zhong, J., Xu, F., Wu, F., Liao, X. ... Yuan, L. (2019). miR‑124 regulates the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sp7. Molecular Medicine Reports, 19, 3807-3814. https://doi.org/10.3892/mmr.2019.10054
MLA
Tang, J., Lin, X., Zhong, J., Xu, F., Wu, F., Liao, X., Cui, R., Li, F., Yuan, L."miR‑124 regulates the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sp7". Molecular Medicine Reports 19.5 (2019): 3807-3814.
Chicago
Tang, J., Lin, X., Zhong, J., Xu, F., Wu, F., Liao, X., Cui, R., Li, F., Yuan, L."miR‑124 regulates the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sp7". Molecular Medicine Reports 19, no. 5 (2019): 3807-3814. https://doi.org/10.3892/mmr.2019.10054